Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Argentine consensus on late-onset Pompe's disease].

Alberto Dubrovsky1, Ernesto Fulgenzi2, Eduardo L De Vito3,4

  • 1Instituto de Neurociencias, Fundación Favaloro, Buenos Aires, Argentina.

Medicina
|September 5, 2018
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Awareness, attitudes, and barriers toward Transthyretin Amyloid Cardiomyopathy in Latin America: A questionnaire-based cross-sectional study.

PloS one·2026
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

When uncertainty is not the problem: science, complexity, and the evaluation of research.

Medicina·2026
Same author

Feasibility and preliminary efficacy of an infant preemptive intervention for prodromes of autism spectrum disorder (ASD) delivered within an Italian tertiary hospital.

Frontiers in child and adolescent psychiatry·2026
Same author

Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Neurology·2026
Same author

Fostering Infant Responsivity and Reciprocity - Support to Thrive (FIRRST): a multisite randomized control trial of a pre-emptive telehealth intervention for infants with early signs of Autism Spectrum Disorders in Italy.

Trials·2026
Summary

This consensus updates management guidelines for delayed-onset Pompe disease (PD), a rare metabolic disorder caused by acid alpha-glucosidase deficiency. It focuses on expert opinions for diagnosis, treatment, and follow-up in adults and children.

Area of Science:

  • Metabolic Disorders
  • Genetics
  • Enzyme Deficiencies

Background:

  • Pompe disease (PD) is a rare, autosomal recessive metabolic disorder.
  • It results from deficient acid alpha-glucosidase enzyme activity.
  • Delayed-onset PD presents after one year of age.

Framework:

  • Update of the 2013 Argentine Consensus on Pompe disease.
  • Expert consensus incorporating recent literature (last 4 years).
  • Multidisciplinary expert panel including internal medicine, neurology, pulmonology, and rehabilitation specialists.

Implementation:

  • Focus on diagnosis, treatment, and follow-up strategies for delayed-onset PD.
  • Literature review with emphasis on the latest research findings.
  • Expert opinion-based recommendations due to limited data.
Keywords:
Pompe's diseaseacid lisosomal maltase deficiencyalfa-glucosidaseconsensusenzyme replacement therapytype II glycogenosis

Related Experiment Videos

Implications:

  • Provides updated clinical guidance for managing delayed-onset Pompe disease.
  • Aims to improve patient outcomes through expert-driven recommendations.
  • Highlights the need for continued research in rare metabolic disorders.